Learn more

LIOMONT S A DE C V LAB

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    162,353
About

LIOMONT S A DE C V LAB has a total of 14 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Mexico, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals are GUANGZHOU ZHONGYI PHARMACEUTIC, PHARMOSA BIOPHARM INC and BIOTEC BIOLOGICA IND FARMACEUTICA LTDA E P P.

Patent filings in countries

World map showing LIOMONT S A DE C V LABs patent filings in countries
# Country Total Patents
#1 Mexico 6
#2 WIPO (World Intellectual Property Organization) 5
#3 Canada 1
#4 Colombia 1
#5 EPO (European Patent Office) 1

Patent filings per year

Chart showing LIOMONT S A DE C V LABs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

# Technology
#1 Medical preparations
#2 Therapeutic chemical compounds

Top inventors

# Name Total Patents
#1 Flores Oliver Daniel Walls 6
#2 Hernández Ramón Rodríguez 6
#3 Walls Flores Oliver Daniel 5
#4 Barreiro Flores Francisco 3
#5 Rodríguez Hernández Ramón 3
#6 Moreno Gisela Espinosa 2
#7 Moreno Hinojosa Raul Arturo 2
#8 Martinez Garcia Leonardo 2
#9 Barrena Hernández Eduardo 2
#10 Hernández Eduardo Barrena 2

Latest patents

Publication Filing date Title
MX2014013240A Pharmaceutical tablet composition for the treatment of erectile dysfunction based on a drug inhibiting the pde5 enzyme (phosphodiesterase type 5).
MX2014008985A Pharmaceutical composition of sodic naproxene, paracetamol and pamabrom, for the treatment of pains related to dysmenorrhoea and/or premenstrual syndrome.
MX2014008984A Obtention process and pharmaceutical composition of capsules of fenofibrate as a lipid regulator of oral administration.
MX2014005151A Pharmaceutical composition and process for obtaining a capsule of thelmisarthan and hydrochlorothiazide.
MX2014005152A Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.
MX2014005153A Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain.
CA2562190A1 Novel antiviral pharmaceutical composition